Background. The effect of preemptive therapy on indirect sequelae associated with
cytomegalovirus (CMV) in liver-transplant recipients has not been clearly delineated …

Cytomegalovirus (CMV) is a major cause of morbidity and mortality following solid organ
transplantation (SOT). Two strategies, prophylactic, and preemptive have emerged for the …

Primary cytomegalovirus (CMV) infection in liver transplant recipients generally occurs
following transmission via a CMV-seropositive donor organ. Occasionally primary infection …

Cytomegalovirus (CMV) is a β-herpesvirus. CMV infections are a common complication
contributing to morbidity and mortality after liver transplantation. Among organ transplant …

To study whether cytomegalovirus (CMV) viremia is a reliable marker of impending CMV
disease and thus a guide for preemptive antiviral therapy, 126 consecutive liver transplant …

Background: Humoral immune responses in cytomegalovirus (CMV) are not studied well.
Pre-transplant CMV immunoglobulin G (IgG) antibody levels (Pre-Tx IgG) could influence the …

INTRODUCTION: Despite recent advances in prevention and treatment, cytomegalovirus
(CMV) is still a major complication in transplant patients. This study sought to analyze the …

Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …

Intoduction Infection by cytomegalovirus (CMV) is a major cause of morbidity among
immunosuppressed patients, especially after solid organ transplantation. The risk of CMV …

Cytomegalovirus (CMV) remains one of the most frequent viral infections and the most
common cause of death after liver transplantation (LT). Chronic allograft liver rejection …